1 Oct 2026, 7:45 pmOthers
Board Meeting Outcome for As Attached Herewith
Outcome without intimation PDF
Natural Biocon (India) Ltd operates in Pesticides & Agrochemicals within the Materials sector.
1,286 historical price candles were omitted because the exchange source has not been verified.
Structured signal from quality, growth, valuation and momentum.
₹ crore, by fiscal year
% of revenue, by fiscal year
Comparable companies from the narrowest available industry classification.
Reported profit and loss, balance sheet, cash flow and growth history.
Annual operating, return, leverage and working-capital ratios.
Current futures and options contracts with compact option-chain pages.
Mutual-fund schemes that disclosed a holding in the company.
Annual reports, exchange filings, offer documents, ratings and earnings-call material.
Upcoming dates and the company’s corporate-action history.
Latest exchange announcements, filings and downloadable documents.
Standalone figures
| Ratio | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Margins | ||||||
| Gross margin % | 30.8% | 39.6% | 29.6% | 6.4% | 11.5% | 14.2% |
| EBITDA margin % | 0% | 18.8% | 19.2% | 1.6% | 0.7% | -2% |
| EBIT margin % | 0% | 18.8% | 19.2% | 1.6% | 0.7% | -2% |
| PAT margin % | 0% | 14.6% | 14.4% | 1.1% | 0.5% | -1.6% |
| Working capital | ||||||
| Receivable days | 1,460 | 373 | 184 | 131 | 247 | 739 |
| Inventory days | 243 | 76 | 382 | 5 | 8 | 0 |
| Payable days | 0 | 25 | 423 | 118 | 270 | 790 |
| NWC days | 1,703 | 423 | 142 | 18 | -14 | -52 |
| Leverage | ||||||
| Current ratio | 44.75 | 13.29 | 1.9 | 1.23 | 1.11 | 0.86 |
| Debt to EBITDA | — | 1.89 | 0.63 | 0.32 | 4.67 | — |
| Debt to equity | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Interest coverage | — | — | — | — | — | — |
| Asset turnover | 0.01 | 0.04 | 0.09 | 0.81 | 0.22 | 0.07 |
| Return ratios | ||||||
| Return on assets % | 0% | 0.6% | 1.3% | 0.9% | 0.1% | -0.1% |
| Return on capital employed % | 0% | 0.7% | 1.9% | 1.8% | 0.3% | -0.2% |
| Return on equity % | 0% | 0.6% | 1.5% | 1.2% | 0.1% | -0.1% |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.
Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.
No scheme among the 32 fund houses on record reported a position in Natural Biocon (India) Ltd. Portfolios are published monthly by each AMC; coverage is still partial.
Documents link to external sources (exchange filings, company investor pages).
| Holder (%) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21.22% | 21.22% | 21.22% | 21.22% | 9.36% | 9.36% | 9.36% | 9.36% | 9.36% | 9.36% | 9.36% | 9.36% | |
| FII | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DII | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 78.78% | 78.78% | 78.78% | 78.78% | 90.64% | 90.64% | 90.64% | 90.64% | 90.64% | 90.64% | 90.64% | 90.64% | |
| No. of shareholders | — | — | — | — | — | — | — | — | 9,541 | 10,166 | 11,027 | 11,352 |
Promoter holding down 11.86 percentage points since Sep 2023.
| Date | Client | Type | Venue | Side | Quantity | Price | Value |
|---|---|---|---|---|---|---|---|
| 13 Aug 2026 | ARUNKUMAR DASHRATHBHAI PRAJAPATI HUF | Bulk | BSE | Sell | 5,16,998 | ₹3.70 | ₹0.19 Cr |
| 13 Aug 2026 | CHOKSHI DIMPLE | Bulk | BSE | Buy | 2,82,973 | ₹3.71 | ₹0.10 Cr |
| 13 Aug 2026 | CHOKSHI DIMPLE | Bulk | BSE | Sell | 3,081 | ₹3.84 | ₹0.00 Cr |
| 12 Aug 2026 | CHOKSHI DIMPLE | Bulk | BSE | Sell | 1,75,615 | ₹4.13 | ₹0.07 Cr |
| 11 Aug 2026 | ARUNKUMAR DASHRATHBHAI PRAJAPATI HUF | Bulk | BSE | Sell | 3,25,162 | ₹4.52 | ₹0.15 Cr |
| 18 Mar 2026 | RAKESH HARLALKA (HUF) | Bulk | BSE | Sell | 1,55,946 | ₹4.52 | ₹0.07 Cr |
| 6 Mar 2026 | SHRAWAN CHOUDHARY | Bulk | BSE | Buy | 2,23,747 | ₹4.50 | ₹0.10 Cr |
| 23 Jan 2026 | CHOKSHI DIMPLE | Bulk | BSE | Buy | 4,35,462 | ₹4.49 | ₹0.20 Cr |
| 23 Jan 2026 | VIJAYKUMAR JAYANTILAL THAKKAR | Bulk | BSE | Sell | 3,68,000 | ₹4.50 | ₹0.17 Cr |
| 17 Nov 2025 | BANU SHAKEELA | Bulk | BSE | Sell | 3,52,359 | ₹4.63 | ₹0.16 Cr |
Current officeholders as filed with BSE. A person holding two offices is listed once per office.
Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.
| Company | Mkt Cap | EV | Revenue | EBITDA | OPM | PAT | NPM | ROCE | ROE | WC Days |
|---|---|---|---|---|---|---|---|---|---|---|
| Upl LimitedUPLUPL | ₹43,628 Cr | ₹65,674 Cr | ₹52,804 Cr | ₹9,326 Cr | 17.9% | ₹2,020 Cr | 4.3% | 11.2% | 6% | 135 |
| Sumitomo Chemical India LimitedSUMICHEMSUMICHEM | ₹20,842 Cr | ₹20,844 Cr | ₹3,245 Cr | ₹685 Cr | 20.7% | ₹579 Cr | 16.8% | 23.1% | 17.3% | 155 |
| Bayer Cropscience LimitedBAYERCROPBAYERCROP | ₹15,958 Cr | — | ₹5,472 Cr | ₹688 Cr | 15.4% | ₹568 Cr | 12.1% | 28.4% | 23.7% | 300 |
| Sharda Cropchem LimitedSHARDACROPSHARDACROP | ₹6,397 Cr | ₹6,397 Cr | ₹5,357 Cr | ₹1,047 Cr | 20.4% | ₹626 Cr | 12.9% | 28% | 24.2% | 125 |
| Dhanuka Agritech LimitedDHANUKADHANUKA | ₹4,217 Cr | ₹4,259 Cr | ₹2,035 Cr | ₹417 Cr | 20.5% | ₹297 Cr | 14.6% | 28.9% | 22.3% | 160 |
| Rallis India LimitedRALLISRALLIS | ₹3,884 Cr | ₹3,942 Cr | ₹2,604 Cr | ₹274 Cr | 10.5% | ₹164 Cr | 6.3% | 13.2% | 10% | 104 |
| Bhagiradha Chemicals & Industries LimitedBHAGCHEMBHAGCHEM | ₹3,063 Cr | ₹3,294 Cr | ₹607 Cr | ₹79 Cr | 10.7% | ₹28 Cr | 3.4% | 4.8% | 2.6% | 148 |
| Nacl Industries LimitedNACLINDNACLIND | ₹3,054 Cr | ₹3,355 Cr | ₹1,519 Cr | ₹106 Cr | 6.5% | ₹12 Cr | 0.3% | 11.8% | 0.8% | 105 |
| Gsp Crop Science LimitedGSPCROPGSPCROP | ₹2,113 Cr | ₹2,373 Cr | ₹1,517 Cr | ₹185 Cr | 12.2% | ₹-3 Cr | 6.2% | 20.7% | -0.4% | 121 |
| Bharat Rasayan LimitedBHARATRASBHARATRAS | ₹1,658 Cr | ₹1,659 Cr | ₹1,203 Cr | ₹177 Cr | 16% | ₹140 Cr | 11.7% | 17.5% | 12.1% | 219 |
| Insecticides (India) LimitedINSECTICIDINSECTICID | ₹1,655 Cr | ₹1,799 Cr | ₹2,060 Cr | ₹210 Cr | 10.6% | ₹125 Cr | 6.5% | 17.1% | 12.1% | 168 |
| Astec Lifesciences LimitedASTECASTEC | ₹1,580 Cr | ₹2,029 Cr | ₹441 Cr | ₹6 Cr | -1% | ₹-67 Cr | -18.1% | -9.3% | -25.9% | 263 |
Board Meeting Outcome for As Attached Herewith
Board Meeting Outcome for Outcome Of Board Meeting Held On 08 September 2026 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Board Meeting Outcome for AGM
Board Meeting Intimation for AGM
Quarterly Results June 30, 2026
Board Meeting Outcome for Quarterly Results June 30, 2026
Board Meeting Intimation for Quarterly Results June 30, 2026
Board Meeting Outcome for Resignation Of Directors
| Date | Category | Subject | Filing |
|---|---|---|---|
| 1 Oct 2026, 7:45 pm | Others Outcome without intimation | Board Meeting Outcome for As Attached Herewith | |
| 9 Sept 2026, 4:49 pm | Others Outcome without intimation | Board Meeting Outcome for Outcome Of Board Meeting Held On 08 September 2026 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015. |
| 5 Sept 2026, 5:36 pm | Board Meeting Outcome of Board Meeting | Board Meeting Outcome for AGM |
| 1 Sept 2026, 7:01 pm | Board Meeting | Board Meeting Intimation for AGM |
| 14 Aug 2026, 7:26 pm | Result Financial Results | Quarterly Results June 30, 2026 |
| 14 Aug 2026, 7:15 pm | Board Meeting Outcome of Board Meeting | Board Meeting Outcome for Quarterly Results June 30, 2026 |
| 11 Aug 2026, 2:12 pm | Board Meeting | Board Meeting Intimation for Quarterly Results June 30, 2026 |
| 14 Jul 2026, 12:53 pm | Others Outcome without intimation | Board Meeting Outcome for Resignation Of Directors |
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| 0 | 0 | 1 | 14 | 8 | 3 | |
| COGS | 0 | 0 | 1 | 13 | 7 | 2 |
| Gross profit | 0 | 0 | 0 | 1 | 1 | 0 |
| 0 | 0 | 0 | 1 | 1 | 0 | |
| 0 | 0 | 0 | 0 | 0 | -0 | |
| OPM % | 0% | 18.8% | 19.2% | 1.6% | 0.7% | -2% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | |
| Profit before tax | 0 | 0 | 0 | 0 | 0 | -0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax % | — | 22.2% | 28% | 30.4% | 33.3% | 0% |
| 0 | 0 | 0 | 0 | 0 | -0 | |
| PAT margin % | 0% | 14.6% | 14.4% | 1.1% | 0.5% | -1.6% |
| EPS (₹) | 0 | 0.1 | 0 | 0 | 0 | -0 |
| EPS adjusted (₹) | 0 | 0.1 | 0.2 | 0.1 | 0 | -0 |
| Annual report | Annual report for Mar 2021 | Annual report for Mar 2022 | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 | — |
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 11 | 11 | 11 | 11 | 26 | 26 |
| Reserves | 1 | 1 | 1 | 1 | 6 | 5 |
| Minority interest | 0 | — | — | — | — | — |
| 0 | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 1 | 4 | 6 | 6 | |
| Total equity & liabilities | 12 | 12 | 14 | 17 | 39 | 37 |
| 0 | 0 | 0 | 0 | 0 | 0 | |
| CWIP | 3 | 3 | 3 | 3 | 3 | 3 |
| Investments | 0 | 0 | 0 | 0 | 21 | 21 |
| 9 | 9 | 10 | 13 | 14 | 12 | |
| Total assets | 12 | 12 | 14 | 17 | 39 | 37 |
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| 0 | 0 | 0 | -0 | 0 | 0 | |
| 0 | -0 | 0 | 0 | -20 | -0 | |
| -0 | 0 | -0 | -0 | 20 | 0 | |
| Net cash flow | 0 | 0 | 0 | -0 | -0 | -0 |
| Free cash flow | 0 | 0 | 0 | -0 | 0 | 0 |
| CFO / Operating profit % | — | 200% | 87.5% | -54.6% | 500% | — |